1. Home
  2. DK vs BCAX Comparison

DK vs BCAX Comparison

Compare DK & BCAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DK
  • BCAX
  • Stock Information
  • Founded
  • DK 2001
  • BCAX 2018
  • Country
  • DK United States
  • BCAX United States
  • Employees
  • DK N/A
  • BCAX N/A
  • Industry
  • DK Integrated oil Companies
  • BCAX
  • Sector
  • DK Energy
  • BCAX
  • Exchange
  • DK Nasdaq
  • BCAX NYSE
  • Market Cap
  • DK 1.0B
  • BCAX 1.0B
  • IPO Year
  • DK 2006
  • BCAX 2024
  • Fundamental
  • Price
  • DK $19.32
  • BCAX $12.08
  • Analyst Decision
  • DK Sell
  • BCAX Strong Buy
  • Analyst Count
  • DK 10
  • BCAX 5
  • Target Price
  • DK $21.22
  • BCAX $41.33
  • AVG Volume (30 Days)
  • DK 1.1M
  • BCAX 591.3K
  • Earning Date
  • DK 02-25-2025
  • BCAX 02-16-2025
  • Dividend Yield
  • DK 5.34%
  • BCAX N/A
  • EPS Growth
  • DK N/A
  • BCAX N/A
  • EPS
  • DK N/A
  • BCAX N/A
  • Revenue
  • DK $13,870,800,000.00
  • BCAX N/A
  • Revenue This Year
  • DK N/A
  • BCAX N/A
  • Revenue Next Year
  • DK N/A
  • BCAX N/A
  • P/E Ratio
  • DK N/A
  • BCAX N/A
  • Revenue Growth
  • DK N/A
  • BCAX N/A
  • 52 Week Low
  • DK $15.36
  • BCAX $11.56
  • 52 Week High
  • DK $33.60
  • BCAX $28.09
  • Technical
  • Relative Strength Index (RSI)
  • DK 57.49
  • BCAX N/A
  • Support Level
  • DK $17.87
  • BCAX N/A
  • Resistance Level
  • DK $20.57
  • BCAX N/A
  • Average True Range (ATR)
  • DK 0.81
  • BCAX 0.00
  • MACD
  • DK 0.18
  • BCAX 0.00
  • Stochastic Oscillator
  • DK 63.66
  • BCAX 0.00

About DK Delek US Holdings Inc.

Delek US Holdings Inc is an integrated energy business focused on petroleum refining, transportation and storage; wholesale crude oil, intermediate, and refined products, and convenience stores retailing. The company owns and operates independent refineries that produce a variety of petroleum products for transportation and industrial markets in the United States. Delek's logistics segment sells portions of the petroleum products its refineries produce. The logistics segment generates revenue through gathering, transporting, and storing crude oil and intermediate products, as well as by marketing, storing, and distributing refined products. The company also offers a collection of retail fuel and convenience stores operating in the Southeast region of the United States.

About BCAX BICARA THERAPEUTICS INC

Bicara Therapeutics Inc is a clinical-stage biopharmaceutical company bringing transformative bifunctional therapies to patients with solid tumors. Its program ficerafusp alfa is a bifunctional antibody that combines two clinically validated targets, an epidermal growth factor receptor, or EGFR, directed monoclonal antibody with a domain that binds to human transforming growth factor beta, or TGF-b.

Share on Social Networks: